We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-3.56%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$18.3B
AUM Growth
-$4.39B
(-19%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-17.47%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
905
New
22
Increased
366
Reduced
338
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sibanye-Stillwater
SBSW
|
+$248M |
| 2 |
Pan American Silver
PAAS
|
+$115M |
| 3 |
Gold Fields
GFI
|
+$93.7M |
| 4 |
NGD
New Gold Inc
NGD
|
+$91.7M |
| 5 |
TAHO
Tahoe Resources Inc
TAHO
|
+$86.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
B
Barrick Mining
B
|
+$299M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$251M |
| 3 |
Newmont
NEM
|
+$243M |
| 4 |
GG
Goldcorp Inc
GG
|
+$224M |
| 5 |
Alamos Gold
AGI
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 53.72% |
| 2 | Energy | 15.99% |
| 3 | Healthcare | 8.05% |
| 4 | Technology | 3.2% |
| 5 | Industrials | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
201
Novo Nordisk
NVO
$213B
| $13.8M | 0.08% |
641,790
-266,308
| -29% | -$5.37M |
|
202
Merck
MRK
$322B
| $13.7M | 0.08% |
224,377
-40,624
| -15% | -$2.47M |
|
203
Sanofi
SNY
$104B
| $13.6M | 0.07% |
283,721
-100,805
| -26% | -$4.82M |
|
204
GSK
GSK
$102B
| $13.4M | 0.07% |
249,480
-74,145
| -23% | -$3.95M |
|
205
AstraZeneca
AZN
$261B
| $13.4M | 0.07% |
196,606
-86,264
| -30% | -$5.63M |
|
206
KLA
KLAC
$286B
| $13.3M | 0.07% |
1,458,650
-780,380
| -35% | -$7.79M |
|
|
GPL
207
DELISTED
Great Panther Mining Limited
GPL
| $13.1M | 0.07% |
1,024,380
-1,687,812
| -62% | -$21.7M |
|
208
AGNC Investment
AGNC
$12.3B
| $13.1M | 0.07% |
614,288
+156,698
| +34% | +$3.26M |
|
209
Ternium
TX
$9.25B
| $12.9M | 0.07% |
458,251
-121,213
| -21% | -$3.09M |
|
|
AMT.PRB
210
DELISTED
American Tower Corporation
AMT.PRB
| $12.7M | 0.07% |
104,667
+2,352
| +2% | +$277K |
|
211
Oil States International
OIS
$522M
| $12.6M | 0.07% |
462,291
+38,403
| +9% | +$1.14M |
|
|
MXIM
212
DELISTED
Maxim Integrated Products
MXIM
| $12.5M | 0.07% |
278,344
-117,493
| -30% | -$5.4M |
|
|
FMSA
213
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $12.4M | 0.07% |
3,181,583
+730,748
| +30% | +$3.79M |
|
214
Viatris
VTRS
$20.1B
| $12.4M | 0.07% |
319,135
-32,524
| -9% | -$1.25M |
|
|
NEE.PRR
215
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $12.3M | 0.07% |
228,367
+5,134
| +2% | +$271K |
|
216
Ionis Pharmaceuticals
IONS
$9.23B
| $12.2M | 0.07% |
239,160
+13,253
| +6% | +$617K |
|
|
SHPG
217
DELISTED
Shire pic
SHPG
| $11.9M | 0.07% |
72,182
-11,945
| -14% | -$2.09M |
|
218
Advanced Micro Devices
AMD
$880B
| $11.8M | 0.06% |
943,940
-401,060
| -30% | -$4.9M |
|
|
NE
219
DELISTED
Noble Corporation
NE
| $11.4M | 0.06% |
3,142,873
-63,649
| -2% | -$293K |
|
220
AGCO
AGCO
$8.49B
| $11.2M | 0.06% |
166,648
+29,476
| +21% | +$1.88M |
|
|
SGEN
221
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.9M | 0.06% |
210,550
+59,205
| +39% | +$3.76M |
|
|
DCUD
222
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $10.7M | 0.06% |
213,142
+4,791
| +2% | +$244K |
|
223
Vale
VALE
$63.1B
| $10.7M | 0.06% |
1,222,851
-297,795
| -20% | -$2.53M |
|
|
KMI.PRA
224
DELISTED
Kinder Morgan, Inc.
KMI.PRA
| $10.7M | 0.06% |
243,591
+5,475
| +2% | +$246K |
|
|
VEDL
225
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $10.6M | 0.06% |
684,221
-181,696
| -21% | -$2.72M |
|
Similar funds
DAM
VanEck Associates's Q2 2017 Portfolio in Review
As of Q2 2017, VanEck Associates held 905 positions worth $18.3B, down 19% from $22.7B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
VanEck Associates withdrew a net $3.2B in Q2 2017, closing 174 positions and reducing 338 holdings. Its most notable exit was VanEck Gold Miners ETF, an estimated $251M position sold in full.
By sector, the portfolio is most concentrated in Materials at 54% of assets, down from 56% a quarter earlier, followed by Energy and Healthcare.
Against the trend, VanEck Associates opened a new position in Silvercorp Metals worth $33.6M.
- VanEck Associates's largest Q2 2017 buy was Silvercorp Metals: 10,496,991 shares worth $33.6M.
- VanEck Associates added most to Sibanye-Stillwater in Q2 2017, an estimated $248M increase.
- VanEck Associates's biggest Q2 2017 reduction was Barrick Mining, cutting an estimated $299M.
- VanEck Associates fully exited VanEck Gold Miners ETF in Q2 2017, selling an estimated $251M.
- VanEck Associates's ten largest holdings make up 29% of its $18.3B portfolio in Q2 2017.
- VanEck Associates opened 22 new positions and closed 174 in Q2 2017.
- VanEck Associates's portfolio value fell 19% quarter-over-quarter to $18.3B.
Based on VanEck Associates's 13F filing for Q2 2017, filed 11 Aug 2017.